Murray Hill, NJ -- January 23, 2002 -- C. R. Bard, Inc. (NYSE-BCR) today announced that it is studying the announcement by Tyco International Ltd. of its plan to separate into four independent publicly traded companies. Bard's Chairman and Chief Executive Officer, William H. Longfield, said, "We are reviewing the impact of Tyco's announcement on our proposed merger, and we and Tyco are engaged in discussions. We will report back to our shareholders when we have more information."

C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of health care products in the fields of vascular, urology, oncology and surgical specialty products.